Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124796062 | 12479606 | 2 | F | 20160510 | 20160627 | 20160620 | 20160704 | EXP | IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-041196 | BRISTOL MYERS SQUIBB | 87.33 | YR | F | Y | 61.00000 | KG | 20160704 | CN | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124796062 | 12479606 | 1 | PS | COUMADIN | WARFARIN SODIUM | 1 | Oral | 5 MG, QMO | Y | 9218 | 5 | MG | TABLET | /month | |||||
| 124796062 | 12479606 | 2 | C | DONEPEZIL. | DONEPEZIL | 1 | Oral | 10 MG, UNK | U | 0 | 10 | MG | |||||||
| 124796062 | 12479606 | 3 | C | PRAMIPEXOLE. | PRAMIPEXOLE | 1 | Intramuscular | 0.18 U, UNK | U | 0 | .18 | DF | |||||||
| 124796062 | 12479606 | 4 | C | AMIODAR | AMIODARONE | 1 | Oral | 200 MG, UNK | U | 0 | 200 | MG | |||||||
| 124796062 | 12479606 | 5 | C | CONGESCOR | BISOPROLOL | 1 | Intramuscular | 5 MG, UNK | U | 0 | 5 | MG | |||||||
| 124796062 | 12479606 | 6 | C | OLPREZIDE | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Oral | 32.5 MG, UNK | U | 0 | 32.5 | MG | |||||||
| 124796062 | 12479606 | 7 | C | METFORAL | METFORMIN HYDROCHLORIDE | 1 | Oral | 850 MG, UNK | U | 0 | 850 | MG | |||||||
| 124796062 | 12479606 | 8 | C | EUTIROX | LEVOTHYROXINE SODIUM | 1 | Oral | 75 ?G, UNK | U | 0 | 75 | UG | |||||||
| 124796062 | 12479606 | 9 | C | LASIX | FUROSEMIDE | 1 | Oral | 25 MG, UNK | U | 0 | 25 | MG | |||||||
| 124796062 | 12479606 | 10 | C | TOTALIP | ATORVASTATIN | 1 | Oral | 20 MG, UNK | U | 0 | 20 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124796062 | 12479606 | 1 | Atrial fibrillation |
| 124796062 | 12479606 | 2 | Product used for unknown indication |
| 124796062 | 12479606 | 3 | Parkinson's disease |
| 124796062 | 12479606 | 4 | Arrhythmia |
| 124796062 | 12479606 | 5 | Hypertension |
| 124796062 | 12479606 | 6 | Hypertension |
| 124796062 | 12479606 | 7 | Diabetes mellitus |
| 124796062 | 12479606 | 8 | Hypothyroidism |
| 124796062 | 12479606 | 9 | Polyuria |
| 124796062 | 12479606 | 10 | Hypercholesterolaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124796062 | 12479606 | OT |
| 124796062 | 12479606 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124796062 | 12479606 | Abdominal distension | |
| 124796062 | 12479606 | Accidental overdose | |
| 124796062 | 12479606 | Dyspnoea | |
| 124796062 | 12479606 | International normalised ratio increased | |
| 124796062 | 12479606 | Oedema peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124796062 | 12479606 | 1 | 20160510 | 0 | ||
| 124796062 | 12479606 | 2 | 20160518 | 0 | ||
| 124796062 | 12479606 | 3 | 20160518 | 0 | ||
| 124796062 | 12479606 | 4 | 20160518 | 0 | ||
| 124796062 | 12479606 | 5 | 20160518 | 0 | ||
| 124796062 | 12479606 | 6 | 20160518 | 0 | ||
| 124796062 | 12479606 | 7 | 20160518 | 0 | ||
| 124796062 | 12479606 | 8 | 20160518 | 0 | ||
| 124796062 | 12479606 | 9 | 20160518 | 0 | ||
| 124796062 | 12479606 | 10 | 20160518 | 0 |